Navigation Links
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Date:9/4/2007

study demonstrated that nebivolol was well tolerated by comparison to placebo treatment. Headache was the most common treatment-related adverse event experienced by 7.1% of the pooled nebivolol-treated patients (dosages of 1.25mg to 40mg once daily) and 7.4% of the placebo-treated patients. Of note, in the pooled nebivolol group, the incidence of AEs commonly associated with traditional beta blocker use, including fatigue (3.6% vs. 2.5% with placebo), erectile dysfunction (0.2%), and depression (0.2%) was low. Moreover, nebivolol was not associated with adverse changes in blood glucose values.

"The publication of nebivolol's first U.S. clinical trial further reinforces its longstanding use in patients worldwide," said Neil Shusterman, M.D., Senior Vice President, Clinical Development, Forest Research Institute. "The majority of Americans afflicted with this disease are still not controlled, so clearly there is a need for more treatment options. This study showed that nebivolol significantly lowered blood pressure in patients with mild-to-moderate hypertension and we anticipate it will be an important therapy for physicians."

About Hypertension

Hypertension, also known as high blood pressure, affects approximately 72 million people in the U.S. and 65 percent of patients diagnosed with hypertension have not reduced their blood pressure to an acceptable range. If left untreated, hypertension can eventually damage important organs such as the heart, brain, eyes or kidneys. High blood pressure greatly increases the risk of certain health problems such as stroke, heart attack, and kidney failure.

About Nebivolol

Nebivolol is a selective beta 1-blocker with vasodilating properties and is already approved and successfully marketed for the treatment of hypertension in more than 50 countries outside of North America.

About Forest Laboratories and Its Products

Forest Laboratories is a US-based pharmaceutical company dedicated to ident
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
2. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
3. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
4. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
8. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a ... Insulin Pumps, today announced the closing of its previously announced ... a price to the public of $11.50 per share, which ... option to purchase up to an additional 787,500 shares. All ... BofA Merrill Lynch and Piper Jaffray ...
(Date:3/4/2015)... 2015 Amgen (NASDAQ: AMGN ) ... $0.79 per share dividend for the second quarter of ... 2015, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:3/4/2015)... MARLTON, N.J. , March 4, 2015 ... brand protection and serialization solutions, announced it will be ... Roosevelt Paper. The live event, "How to Boost Manufacturing ... on Wednesday, March 18th at 2:00 PM EDT.  ... Officer for Acsis, and John Gordon , Chief ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock 2Amgen Announces 2015 Second Quarter Dividend 2Amgen Announces 2015 Second Quarter Dividend 3
... Ajinomoto Co., a leader in the development of ... has announced that its patented dietary supplement Capsiate ... on the Principal Register of the United States ... latest milestone for Capsiate Natura®, the first and ...
... Uroplasty, Inc. (Nasdaq: UPI ), a ... proprietary products to treat voiding dysfunctions, announced today that ... 23rd Annual OC Growth Stock Conference on Monday, March ... Ritz-Carlton Laguna Nigel. David Kaysen, Uroplasty,s President and CEO, ...
Cached Medicine Technology:Ajinomoto Co.'s Capsiate Natura® Reaches New Milestone 2Uroplasty to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference 2
(Date:3/5/2015)... In recognition of its ongoing commitment ... Flordis International (SFI) has been honored by the American ... natural medicine company committed to identifying and developing natural ... and effectiveness. For these efforts the non-profit ABC selected ... in Phytomedicinal Research Award. , Phytomedicinal research seeks ...
(Date:3/5/2015)... 05, 2015 March is National ... campaign sponsored by the Academy of Nutrition and ... Healthy Lifestyle," which promotes the consumption of fewer ... achieving and maintaining a healthy weight, reducing risks ... , Whether a person is new to physical ...
(Date:3/5/2015)... GA (PRWEB) March 05, 2015 The ... Fu for Health and Wellness at Atlanta Shaolin Institute ... on 4350 Peachtree Industrial BLVD, Suite 500A, city of ... (Shaolin Chan Foundation), which is a non-profit organization that ... arts, philosophy and medicine. , The seminar was ...
(Date:3/5/2015)... March 05, 2015 Medical professionals suggest ... here—and it’s a crisis that is worsening. The demand ... order to stay on top of the physician shortage, ... PracticeLink to meet face-to-face with physicians and advanced practitioners ... and Job Fair series. , Physician openings take an ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 Understanding China’s ... — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs ... and revamped regulations for medical devices in China. ... medical devices — research and development, approval, manufacturing, distribution, ... — those currently in development as well as those ...
Breaking Medicine News(10 mins):Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 2Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 3Health News:Physician Shortage Crisis Worsening 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3
... First-of-Its-Kind Device To Aid Dentists & Doctors in Detecting Oral ... More Deadly Than Breast, Cervical, or Prostate Cancers , HOUSTON, ... to aid in early detection, dentists, hygienists, and doctors have ... -- oral cancer , ...
... Pharmaceuticals USA, the leading generic pharmaceutical company, today ... to push for more affordable healthcare. The program, ... 25th anniversary of the landmark Waxman-Hatch Act which ... resulted in billions of dollars of savings."With a ...
... Service Corporation,International (NYSE: SCI ), which ... that its Board of Directors has approved a,quarterly cash ... The,quarterly cash dividend announced today is payable on ... of business on April 15, 2009. While the,Company ...
... new biological marker present in the urine of patients ... progressing and spreading. , In experiments reported in the ... the scientists identified 10 metabolites that become more ... showed that one of these chemicals, sarcosine, helps prostate ...
... 11 This Valentine,s Day, Berry Chill is,offering a ... any chilled yogurt,order, they,ll receive a free Valentine,s Day ... with fresh strawberries, pomegranate and,chocolate chips. , ... and the pair must,place the order together. Subtractions from ...
... Feb. 11 ActivCore LLC, a,leading company ... Redcord,products in the United States, announces the ... (WIM). ActivCore will leverage WIM,s training,infrastructure ... will serve,therapy professionals, chiropractors, fitness club professionals, ...
Cached Medicine News:Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 2Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 3Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 4Health News:Teva Launches National Advocacy Campaign for Affordable Healthcare 2Health News:Service Corporation International Declares Quarterly Cash Dividend 2Health News:Service Corporation International Declares Quarterly Cash Dividend 3Health News:Survey of metabolites finds new prostate cancer marker 2Health News:Survey of metabolites finds new prostate cancer marker 3Health News:Berry Chill Offers Sweet Valentine's Day Deal for Couples 2Health News:ActivCore LLC Announces Strategic Partnership with Wellness in Motion 2
Used to establish and temporarily maintain suprapubic access during endoscopic procedures. Supplied sterile in peel-open packages. Intended for one-time use....
... is a minimally invasive tension-free sling ... incontinence resulting from urethral hypermobility (Type ... Stratasis TF Kit is designed to ... placement. Supplied sterile in peel-open ...
... a Roadrunner, Bentson, or other flexible tipped ... beyond a redundant or tortuous ureteral segment. ... around and beyond a ureteral stone, or ... stone from the mucosal wall. Supplied sterile ...
... of contrast medium, anesthetic gel, and/or safety ... the need for multiple catheterizations. The Flexi-Tip ... into and through the ureter. AQ is ... when activated, attracts and holds water and ...
Medicine Products: